Use of betahistine in the treatment of peripheral vertigo

Acta Oto-Laryngologica

Volumn 135, Issue 12, 2015, Pages 1205-1211

  Ramos Alcocer, Rubén ^a   Ledezma Rodríguez, José Gregorio ^b   Navas Romero, Antonio ^c   Cardenas Nuñez, José Luis ^d   Rodríguez Montoya, Vicente ^e   Deschamps, Jose ^f   Liviac Ticse, Jorge Anibal ^g  

^a Otorrinolaringologo y Neurotologo Medicentro Del Parque   (Mexico)

^b Hospital Militar Dr Carlos Arvelo   (Venezuela)

^c Servicio de ORL   (Ecuador)

^d UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^e Clinica la Colina   (Colombia)

^f Centro de Otorrinolaringología y Especialidades   (Dominica)

^g Clínica Privada Jorge Anibal Liviac Ticse   (Peru)

Author keywords

benign paroxysmal positional vertigo; M ni res disease; neuronitis; prevention; treatment; vestibular compensation

Indexed keywords

BETAHISTINE; PLACEBO; HISTAMINE AGONIST;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); DRUG ABSORPTION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DYSPEPSIA; HEADACHE; HUMAN; MAXIMUM PLASMA CONCENTRATION; MENIERE DISEASE; META ANALYSIS (TOPIC); NAUSEA; NONHUMAN; PERIPHERAL VERTIGO; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; URINARY EXCRETION; VERTIGO; VOMITING; BODY EQUILIBRIUM; DRUG EFFECTS; META ANALYSIS; PATHOPHYSIOLOGY; QUALITY OF LIFE; VESTIBULAR LABYRINTH;

BETAHISTINE; HISTAMINE AGONISTS; HUMANS; POSTURAL BALANCE; QUALITY OF LIFE; VERTIGO; VESTIBULE, LABYRINTH;

EID: 84942503347     PISSN: 00016489     EISSN: 16512251     Source Type: Journal    
DOI: 10.3109/00016489.2015.1072873     Document Type: Review

References (20)

1. Strupp M, Dieterich M, Brandt T. The treatment and natural course of peripheral and central vertigo. Dtsch Arztebl Int 2013; 110: 505-15.
2. Strupp M, Thurtell MJ, Shaikh AG, Brandt T, Zee DS, Leigh RJ. Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol 2011; 258: 1207-22.
3. Brandt T, Zwergal A, Strupp M. Medical treatment of vestibular disorders. Expert Opin Pharmacother 2009; 10: 1537-48.
4. Neuhauser HK. Epidemiology of vertigo. Curr Opin Neurol 2007; 20: 40-6.
5. James AL, Burton MJ. Betahistine for Ménières disease or syndrome. Cochrane Database Syst Rev 2001; CD001873.
6. Strupp M, Zwergal A, Feil K, Bremova T, Brandt T. Pharmacotherapy of vestibular and cerebellar disorders and downbeat nystagmus: translational and back-translational research. Ann N Y Acad Sci 2015; 1343: 27-36.
7. Stambolieva K, Angov G. Effect of treatment with betahistine dihydrochloride on the postural stability in patients with different duration of benign paroxysmal positional vertigo. Int Tinnitus J 2010; 16: 32-6.
8. Hilton MP, Pinder DK. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev 2014; 12: CD003162.
9. Frew IJ, Menon GN. Betahistine hydrochloride in Méniéres disease. Postgrad Med J 1976; 52: 501-3.
10. Lacour M, van de Heyning PH, Novotny M, Tighilet B. Betahistine in the treatment of Ménières disease. Neuropsychiatr Dis Treat 2007; 3: 429-40.
11. Nauta JJ. Meta-analysis of clinical studies with betahistine in Ménières disease and vestibular vertigo. Eur Arch Otorhinolaryngol 2014; 271: 887-97.
12. Arrang JM, Garbarg M, Quach TT, Dam Trung Tuong M, Yeramian E, Schwartz JC. Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 1985; 111: 73-84.
13. Gbahou F, Davenas E, Morisset S, Arrang JM. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo. J Pharmacol ExpTher 2010; 334: 945-54.
14. Botta L, Mira E, Valli S, Zucca G, Benvenuti C, Fossati A, et al. Effects of betahistine and of its metabolites on vestibular sensory organs. Acta Otorhinolaryngol Ital 2001; 21 (3 Suppl 66): 24-30.
15. Mira E, Guidetti G, Ghilardi PL, Fattori B, Fattori B, Malannino N, et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo. Eur Arch Otorhinolaryngol 2003; 260: 73-7.
16. Della Pepa C, Guidetti G, Eandi M. Betahistine in the treatment of vertiginous syndromes: a meta-analysis. Acta Otorhinolaryngol Ital 2006; 26: 208-15.
17. Guneri EA, Kustutan O. The effects of betahistine in addition to Epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 2012; 146: 104-8.
18. Djelilovic-Vranic J, Alajbegovic A, Tiric-Campara M. Betahistine or Cinnarizine for treatment of Ménières disease. Med Arch 2012; 66: 396-8.
19. Colletti V. Medical treatment in Ménières disease: avoiding vestibular neurectomy and facilitating postoperative compensation. Acta Otolaryngol (Suppl) 2000; 544: 27-33.
20. Ganança MM, Caovilla HH, Ganança FF. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménières disease. Acta Otolaryngol 2009; 129: 487-92.